Advertise with us
Medical Group

Journal of Vaccines and Immunology

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Type of LicenseCreative Commons
    • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
      • Permanent article identifierDOI (Digital Object Identifier)
    • Show +

    Editorial Board Join as Editor

    Andrea Poscia
    Public Health Institute
    Catholic University of Sacred Heart of Rome
    Italy
    andreaposcia83@gmail.com
    JVI

    Research Interest: HTA and to new communication strategies with people about vaccination, especially in consideration of the rising phenomena of anti-vaccination movements.

    More Info.
    Roman Chlibek
    Professor
    Department of Epidemiology
    University of Defence
    Czech Republic
    roman.chlibek@unob.cz
    JVI

    Research Interest: Infection diseases prevention, epidemiology of infectious diseases, vaccination, vaccines, travel and tropical medicine.

    More Info.
    Julie Bouckaert
    Researcher
    Computational Molecular Systems Biology
    Lille University of Science and Technology
    France
    julie.bouckaert@univ-lille1.fr
    JVI

    Research Interest: Structure-to-function relationships of microbial lectins Structural study of multivalent protein-carbohydrate interactions Analysis of differential glycosylation and bacterial infection pathology during metabolic imbalance Structure-based design of anti-bacterial and anti-fungal drugs.

    More Info.
    Yadong Zheng
    Lanzhou Veterinary Research Institute
    Chinese Academy of Agricultural Sciences
    China
    zhengyadong@caas.cn
    JVI

    Research Interest: Vaccine, innate immunity, parasite-host interaction.

    More Info.
    Michel Klein
    Professor of Immunology
    University of Toronto
    Canada
    michel.klein@umontreal.ca
    JVI

    Research Interest: Vaccine development.

    More Info.
    Regis Sodoyer
    Technology Research Institute Bioaster
    France
    regis.sodoyer@bioaster.org
    JVI

    Research Interest: Plant biotechnology, Regulation of expression by anti-messengers & ribozymes, Systems Biology.

    More Info.
    Ernesto Oviedo-Ortas
    Clinical Sciences Expert
    Novartis Vaccines and Diagnostics
    Italy
    ernesto.oviedo-orta@novartis.com
    JVI

    Research Interest: Clinical Immunology.

    More Info.
    Yu-Chen Hu
    Department of Chemical Engineering
    National Tsing Hua University
    Taiwan
    ychu@mx.nthu.edu.tw
    JVI

    Research Interest: Gene therapy, Cell and tissue engineering, Vaccine development, Biomaterials, Synthetic biology and biomass, Nanobiotechnology.

    More Info.
    Mingsheng Cai
    Depaertment of Pathogenic Biology and Immunology
    Guang zhou Medical University
    China
    mingshengcai@hotmail.com
    JVI

    Research Interest: Molecular mechanisms of immune evasion of EBV and HSV-1. Molecular mechanisms of EBV and HSV-1 infection and its interaction with the host. Mechanisms of pathogenesis of EBV and HSV-1 infection.

    More Info.
    David Allen Reardon
    Center for Neuro-Oncology Dana-Farber Cancer Institute
    USA
    David_Reardon@DFCI.harvard.edu
    JVI

    Research Interest: Innovative Clinical Therapeutic Agents To Improve Cure Rates In Patients With Brain And Spinal Tumors, With Particular Focus On Immunotherapeutics As Well As Molecular-Targeting Agents, Anti-Angiogenic Reagents, Cytotoxins And Other Biologically-Based Therapies.

    More Info.
    Li Junwei
    Texas Tech University
    USA
    junwei.li@ttuhsc.edu
    JVI

    Research Interest: My Research Focus on Design Universal and Live Attenuated Influenza Vaccine by using Novel Methods, and Testingthese New Generation Vaccine Candidates in Humanized Mice and Ferrets. As Well, We would like to explore the Mechanism of Cross-Protection induced by live Attenuated Influenza against seasonal and Pandemic Influenza Viruses. Our Results Suggested That Activation of T cell Is Crucial for the cross Protection Stimulated By vaccination With Live Attenuated Influenza Vaccine. In Future Research, We Will Focus on B Cell Development Stimulated by Vaccination with Live Attenuated Influenza vaccine. To Facilitate The Development Of More Effective Vaccines, We Are Also Researching: The Effect Of Current Vaccination Programs On The Epidemiological Changes Of Respiratory Pathogens (Strain Replacement And Antigenic Variation); How People Respond To Infections Or Vaccinations At The Cellular And Molecular Levels (B Cell, T Cell, And Gene expression Levels) identification of New Protective Antigens Through Genomic And Proteomic Approaches.

    More Info.
    Salvatore Chirumbolo
    Professor
    Department of Pathology and Diagnostics
    University of Verona
    Italy
    salvatore.chirumbolo@univr.it
    JVI

    Research Interest: Allergy test in clinical diagnosis, Immunotherapy and in vitro cell assay, Anti-inflammatory properties of natural compounds, Allergy and vaccination, Basophil activation tests.

    More Info.
    Ting Wang
    Professor, School of Pharmacy
    Anhui Medical University
    China
    twangcn@hotmail.com
    JVI

    Research Interest: Nanoparticles, liposomes, solid lipid naonparticles, and anhydrous reverse micelles, drug/vaccine carriers, freeze-drying of pharmaceutics, design, carrying out and analysis of in vivo tests, separation and purification of chemicals, extraction and analysis of therapeutic.

    More Info.
    Ali Azizi
    Professor
    University of Ontario Institute of Technology
    Canada
    Ali.Azizi@sanofipasteur.com
    JVI

    Research Interest: Conduct several molecular biology and genomic assays including Sequencing, Cloning, RT-PCR, Southern blot, Northern blot, and Immunostaining.

    More Info.
    Weida Liu
    Professor
    Head, Department of Medical Mycology
    Chinese Academy of Medical Sciences
    China
    liumyco@hotmail.com
    JVI

    Research Interest: Diagnosis of fungal infections; Therapy of mycoses; Pathogenesis of fungal infection; Antifungal drug resistance; Fungal infection animal model; Genomics in medical mycology; Candida mucosal immunity; Infectious dermatosis; genodermatoses.

    More Info.
    View more

    Measuring autophagy level along with vaccine reactive IFN-+CD4+ Th1 cells may be a promising approach to understand effi cacy of anti TB vaccine(s)

    Published On: March 21, 2018 | Pages: 001 - 003

    Author(s): Om Parkash*
    Abstract View Full Article View DOI: 10.17352/jvi.000022

    Construction of Indonesian-Strain Avian Flu Virus Seed Vaccine Using Low Pathogenic Hemagglutinin Gene and Neuraminidase Pr8 Gene through Reverse Genetics

    Published On: August 17, 2017 | Pages: 005 - 011

    Author(s): Reviany Vibriaanita Nidom, Muh Y Alamudi, Sahrir Sillehu, Setyarina Indrasari, Rahmalia D Suindarti, Ema Qurnianingsih, Yoes P Dachlan, Aryati, Ahmad Syahrani, Kadek Rachmawati, Kuncoro P Santoso and Chairul A Nidom*
    Abstract View Full Article View DOI: 10.17352/jvi.000021

    Preparation and Application of two Monoclonal Antibodies against Canine Parvovirus Vaccine and Field Strains.

    Published On: May 02, 2017 | Pages: 001 - 004

    Author(s): Liying Hao#, Ying Wang#, Chenyu Bai, Yudan Jin, Dingding Zheng, Lingyan Chen, Xiangdong Li, Junhua Deng and Kegong Tian*
    Abstract View Full Article View DOI: 10.17352/jvi.000020

    Immunoprophylactic Control Strategy for Tropical Fasciolosis: A Possibility

    Published On: December 30, 2016 | Pages: 036 - 040

    Author(s): Niranjan Kumar*, Prem Sagar Maurya, Jayesh B Solanki and Anil Kumar Mishra
    Abstract View Full Article View DOI: 10.17352/jvi.000019

    IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1

    Published On: December 17, 2016 | Pages: 026 - 035

    Author(s): Ingrid Rodríguez-Alonso, Daymir García, Emma Brown, Stephane Ascarateil and Enrique Iglesias*
    Abstract View Full Article View DOI: 10.17352/jvi.000018

    Pathogenicity of Duck-Originated H9N2 Influenza Viruses on Chickens

    Published On: November 14, 2016 | Pages: 023 - 025

    Author(s): Kunkun Zhao, Chunxia Jin, Yuxin Huang, Haiyang Zhang, Jingjing Xue, Hui Tian, Yue Yuan, Xiangdong Li, Wujie Liu* and Kegong Tian*
    Abstract View Full Article View DOI: 10.17352/jvi.000017

    Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus

    Published On: October 25, 2016 | Pages: 019 - 022

    Author(s): Yi Cheng, Dongbei Sheng, Xiangdong Li, Sumei Hong, Lixia Guo, Shasha Zhao, Yue Yuan, Jingjing Xue, Hui Tian, Yipin Ren, Wujie Liu* and Kegong Tian*
    Abstract View Full Article View DOI: 10.17352/jvi.000016

    Prospects for the Development of a Dengue Vaccine

    Published On: August 10, 2016 | Pages: 015 - 018

    Author(s): Usa Thisyakorn* and Chule Thisyakorn
    Abstract View Full Article View DOI: 10.17352/jvi.000015

    Immunity against Pasteurella multocida in Animals Vaccinated with Inactivated Pasteurella multocida and Herbal Adjuvant 'DIP-HIP'

    Published On: July 16, 2016 | Pages: 010 - 014

    Author(s): Himanshi Tanwar, Anand Prakash Yadav, Brijbhushan, Shweta, Shashi Bala Singh, and Lilly Ganju*
    Abstract View Full Article View DOI: 10.17352/jvi.000014

    Supercritical Carbon Dioxide Extract of Seabuckthorn Leaves Enhances Rabies Virus Neutralizing Antibody Titers and CTL Response in Swiss Albino Mice

    Published On: June 17, 2016 | Pages: 004 - 009

    Author(s): B Jayashankar, D Singh, KP Mishra*, SN Madhusudana, Ashwin YB, SB Singh, and L Ganju
    Abstract View Full Article View DOI: 10.17352/jvi.000013

    Advertisements

    Peertechz @Social

    Peertechz Tweets

    Case Reports

    Pinterest on JVI